GERN - Geron Corp.
IEX Last Trade
4.75
0.190 4.000%
Share volume: 11,113,159
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.56
0.19
4.17%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-11 | 2022-11-07 | 2023-03-16 | 2023-05-11 | 2023-08-03 | 2023-11-02 | 2024-02-28 | 2024-05-02 | |
Total revenue | 73.000 K | 297.000 K | 103.000 K | 21.000 K | 29.000 K | 164.000 K | 23.000 K | 304.000 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 73.000 K | 297.000 K | 103.000 K | 21.000 K | 29.000 K | 164.000 K | 23.000 K | 304.000 K | |
306.85% | -65.32% | -79.61% | 38.10% | 465.52% | -85.98% | 1,221.74% | |||
Operating expenses | 28.049 M | 40.245 M | 42.054 M | 40.113 M | 51.980 M | 47.776 M | 54.312 M | 56.438 M | |
Selling general and admin | 7.443 M | 15.642 M | 13.844 M | 12.894 M | 16.490 M | 18.350 M | 21.401 M | 27.065 M | |
Research and development | 20.606 M | 24.603 M | 28.210 M | 27.219 M | 35.490 M | 29.426 M | 32.911 M | 29.373 M | |
Total expenses | 28.049 M | 40.245 M | 42.054 M | 40.113 M | 51.980 M | 47.776 M | 54.312 M | 56.438 M | |
43.48% | 4.49% | -4.62% | 29.58% | -8.09% | 13.68% | 3.91% | |||
Operating income | -27.976 M | -39.948 M | -41.951 M | -40.092 M | -51.951 M | -47.612 M | -54.289 M | -56.134 M | |
Ebit | -27.976 M | -39.948 M | -41.951 M | -40.092 M | -51.951 M | -47.612 M | -54.289 M | -56.134 M | |
Pretax income | -28.117 M | -41.051 M | -42.635 M | -38.122 M | -49.227 M | -44.805 M | -51.973 M | -55.390 M | |
46.00% | 3.86% | -10.59% | 29.13% | -8.98% | 16.00% | 6.57% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -28.117 M | -41.051 M | -42.635 M | -38.122 M | -49.227 M | -44.805 M | -51.973 M | -55.390 M | |
-46.00% | -3.86% | 10.59% | -29.13% | 8.98% | -16.00% | -6.57% | |||
Net income | -28.117 M | -41.051 M | -42.635 M | -38.122 M | -49.227 M | -44.805 M | -51.973 M | -55.390 M | |
-46.00% | -3.86% | 10.59% | -29.13% | 8.98% | -16.00% | -6.57% |